Inmode Share Price (NASDAQ: INMD)

$14.93

▲

0.01

(0.07%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Inmode Stock chart to analyse performance

Inmode stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$14.80
Today's High:$14.98
$14.93
0.87%
Downside
Day's Volatility :1.2%
Upside
0.33%
52 Weeks Low:$13.14
52 Weeks High:$19.85
$14.93
11.99%
Downside
52 Weeks Volatility :33.8%
Upside
24.79%

Inmode Stock Returns

Period	Inmode Ltd	Sector (Health Care)	Index (Russel 2000)
3 Months	4.01%	3.6%	0.0%
6 Months	-20.99%	-7.7%	0.0%
1 Year	-5.06%	-12.6%	0.0%
3 Years	-52.06%	10.2%	-4.1%

Inmode Ltd Key Stats

Check Inmode key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$14.92
Open	$14.89
Today's High	$14.98
Today's Low	$14.8
Market Capitalization	$944.3M
Today's Volume	$1.7M
52 Week High	$19.85
52 Week Low	$13.14
Revenue TTM	$401.6M
EBITDA	$115.4M
Earnings Per Share (EPS)	$2.38
PE Ratio	6.28
Profit Margin	44.5%
Quarterly Earnings Growth YOY	0.5%
Return On Equity TTM	25.91%

Stock Returns calculator for Inmode Stock including INR - Dollar returns

The Inmode stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Inmode investment value today

Current value as on today

₹1,00,259

Returns

₹259

(+0.26%)

Returns from Inmode Stock

₹5,025 (-5.03%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Inmode Stock

14%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Inmode Stock from India on INDmoney has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Inmode Ltd

Name
Holdings %
Name
Holdings %
BlackRock Inc
8.93%
Renaissance Technologies Corp
3.65%
Doma Perpetual Capital Management LLC
3.54%
LSV Asset Management
3.07%
State Street Corp
2.90%
UBS Group AG
2.64%

Analyst Recommendation on Inmode Stock

Rating

Trend

Buy

66%Buy

33%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Inmode(by analysts ranked 0 to 5 stars)

Inmode Share Price Target

What analysts predicted

Upside of 8.84%

Target:

$16.25

Current:

$14.93

Inmode share price target is $16.25, a slight Upside of 8.84% compared to current price of $14.93 as per analysts' prediction.

Inmode Stock Insights

Price Movement
In the last 6 months, INMD stock has moved down by -20.3%
Increasing Revenue
Revenue is up for the last 2 quarters, 77.87M → 95.60M (in $), with an average increase of 18.5% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 18.20M → 26.74M (in $), with an average increase of 31.9% per quarter
INMD vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 39.7%
INMD vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 161.7% return, outperforming this stock by 215.0%
Price to Sales
ForINMD every $1 of sales, investors are willing to pay $2.6, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Inmode Ltd Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$156.4M	↑ 56.11%
Net Income	$61.1M	↑ 173.32%
Net Profit Margin	39.11%	↑ 16.78%

	FY20	Y/Y Change
Revenue	$206.1M	↑ 31.81%
Net Income	$75.0M	↑ 22.71%
Net Profit Margin	36.4%	↓ 2.71%

	FY21	Y/Y Change
Revenue	$357.6M	↑ 73.49%
Net Income	$165.0M	↑ 119.87%
Net Profit Margin	46.14%	↑ 9.74%

	FY22	Y/Y Change
Revenue	$454.3M	↑ 27.05%
Net Income	$161.5M	↓ 2.09%
Net Profit Margin	35.56%	↓ 10.58%

	FY23	Y/Y Change
Revenue	$492.0M	↑ 8.32%
Net Income	$197.9M	↑ 22.54%
Net Profit Margin	40.22%	↑ 4.66%

	FY24	Y/Y Change
Revenue	$394.8M	↓ 19.76%
Net Income	$181.3M	↓ 8.41%
Net Profit Margin	45.91%	↑ 5.69%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$80.3M	↓ 36.68%
Net Income	$23.7M	↓ 57.05%
Net Profit Margin	29.52%	↓ 13.99%

	Q2 FY24	Q/Q Change
Revenue	$86.4M	↑ 7.68%
Net Income	$23.8M	↑ 0.51%
Net Profit Margin	27.55%	↓ 1.97%

	Q3 FY24	Q/Q Change
Revenue	$130.2M	↑ 50.65%
Net Income	$51.0M	↑ 114.08%
Net Profit Margin	39.15%	↑ 11.6%

	Q4 FY24	Q/Q Change
Revenue	$97.9M	↓ 24.86%
Net Income	$82.8M	↑ 62.33%
Net Profit Margin	84.59%	↑ 45.44%

	Q1 FY25	Q/Q Change
Revenue	$77.9M	↓ 20.42%
Net Income	$18.2M	↓ 78.01%
Net Profit Margin	23.37%	↓ 61.22%

	Q2 FY25	Q/Q Change
Revenue	$95.6M	↑ 22.76%
Net Income	$26.7M	↑ 46.93%
Net Profit Margin	27.97%	↑ 4.6%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$136.1M	↑ 59.95%

	FY20	Y/Y Change
Profit	$175.3M	↑ 28.75%

	FY21	Y/Y Change
Profit	$304.0M	↑ 73.44%

	FY22	Y/Y Change
Profit	$380.8M	↑ 25.27%

	FY23	Y/Y Change
Profit	$411.3M	↑ 8.02%

	FY24	Y/Y Change
Profit	$317.1M	↓ 22.92%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$63.9M	↓ 39.99%

	Q2 FY24	Q/Q Change
Profit	$69.3M	↑ 8.47%

	Q3 FY24	Q/Q Change
Profit	$106.2M	↑ 53.14%

	Q4 FY24	Q/Q Change
Profit	$77.6M	↓ 26.88%

	Q1 FY25	Q/Q Change
Profit	$60.9M	↓ 21.54%

	Q2 FY25	Q/Q Change
Profit	$76.5M	↑ 25.51%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$62.2M	↑ 68.64%
Investing Cash Flow	$-112.5M	↑ 278.13%
Financing Cash Flow	$70.2M	↑ 37627.42%

	FY20	Y/Y Change
Operating Cash Flow	$79.2M	↑ 27.36%
Investing Cash Flow	$-43.3M	↓ 61.49%
Financing Cash Flow	$-12.4M	↓ 117.73%

	FY21	Y/Y Change
Operating Cash Flow	$174.9M	↑ 120.74%
Investing Cash Flow	$-160.1M	↑ 269.72%
Financing Cash Flow	$-15.0M	↑ 20.74%

	FY22	Y/Y Change
Operating Cash Flow	$181.6M	↑ 3.83%
Investing Cash Flow	$-109.5M	↓ 31.62%
Financing Cash Flow	$-41.1M	↑ 173.5%

	FY23	Y/Y Change
Operating Cash Flow	$176.8M	↓ 2.62%
Investing Cash Flow	$-136.1M	↑ 24.29%
Financing Cash Flow	$5.5M	↓ 113.4%

	FY24	Y/Y Change
Operating Cash Flow	$132.7M	↓ 24.97%
Investing Cash Flow	$162.2M	↓ 219.21%
Financing Cash Flow	$-282.8M	↓ 5237.55%

Q1 FY24

Q2 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$24.1M	↓ 60.64%
Investing Cash Flow	$-47.4M	↓ 8.32%
Financing Cash Flow	$234.0K	↓ 14.91%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$41.5M	↑ 72.17%
Investing Cash Flow	$18.0M	↓ 137.92%
Financing Cash Flow	$-87.9M	↓ 37647.42%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$32.4M	↓ 4.72%
Investing Cash Flow	$77.8M	-
Financing Cash Flow	$-118.4M	↑ 55.85%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$14.0M	↓ 56.71%
Investing Cash Flow	$75.5M	↓ 3.0%
Financing Cash Flow	$-99.5M	↓ 16.01%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$24.3M	↑ 72.71%
Investing Cash Flow	$72.4M	↓ 4.13%
Financing Cash Flow	$-27.6M	↓ 72.26%

Inmode Technicals Summary

Sell

Neutral

Buy

Inmode is currently in a neutral trading position according to technical analysis indicators.

Inmode Ltd Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inmode Ltd	8.62%	-20.99%	-5.06%	-52.06%	-3.08%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	4.24%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inmode Ltd	6.28	6.28	2.9	1.57	0.26	0.09	NA	9.94
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inmode Ltd	Buy	$944.3M	-3.08%	6.28	44.5%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Inmode Ltd

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Organization	Inmode
Employees	599
CEO	Mr. Moshe Mizrahy
Industry	Health Technology

Key Management of Inmode Ltd

Name	Title
Mr. Yair Malca	Chief Financial Officer
Mr. Matt Rodgers	Vice President of Sales of Canada
Mr. Brandon Nye	Vice President of Sales of West US
Mr. Michael Dennison	Vice President of Sales - East US
Mr. Moshe Mizrahy	Co-Founder, CEO & Director
Dr. Michael Kreindel	Co-Founder, CTO & Director
Ms. Nava Tal-Launer	Chief Information Officer

Important FAQs about investing in INMD Stock from India :

What is Inmode share price today?

Inmode share price today is $14.93 as on August 30, 2025 at 1:29 am IST at the close of the market. Inmode share today touched a day high of $14.98 and a low of $14.80.

What is the 52 week high and 52 week low for Inmode share?

Inmode share touched a 52 week high of $19.85 and a 52 week low of $13.14. Inmode stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $14.93, lower by 24.79% versus the 52 week high.

How to invest in Inmode Stock (INMD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Inmode on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inmode Shares that will get you 0.1005 shares as per Inmode share price of $14.93 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Inmode Stock (INMD) from India?

Indian investors can start investing in Inmode (INMD) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Inmode stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Inmode share’s latest price of $14.93 as on August 30, 2025 at 1:29 am IST, you will get 0.6698 shares of Inmode. Learn more about fractional shares .

What are the returns that Inmode has given to Indian investors in the last 5 years?

Inmode stock has given -3.08% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?